NAGE
Niagen Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$3.17
+1.93%Margins
Gross margin
64.2%
EBITDA margin
14.3%
EBIT margin
6.7%
Net margin
12.4%
FCF margin
4.4%
19.4%
Return on equity
15.0%
Return on assets
10.2%
Return on invested capital
1.17x
Asset turnover
$5.9M
Cash from operations
$0.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026